Synta Pharmaceuticals Corp. (NASDAQ:SNTA)
CAPS Rating:
A biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs that address severe medical conditions with potential markets, including cancer and chronic inflammatory diseases.
RSS Headlines
Fool UK
Recs
wallstreet buy list
Wall street buy list as of September 2008, A LOT LOT LOT of things have changed since then.